Published in Prostaglandins on April 01, 1997
13C-urea versus 14C-urea breath test: is there still a need for 14C-urea? Nucl Med Commun (1998) 2.06
Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill? Crit Care Med (2003) 1.87
Comparison of root canal preparation using RaCe and ProTaper rotary Ni-Ti instruments. Int Endod J (2005) 1.64
Incidence of pseudoaneurysm after diagnostic and therapeutic angiography. Radiology (1995) 1.43
Association of nutritional risk index with metabolic biomarkers, appetite-regulatory hormones and inflammatory biomarkers and outcome in patients with chronic heart failure. Int J Clin Pract (2014) 1.41
Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages. Eur Heart J (1993) 1.41
Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. Wien Klin Wochenschr (1998) 1.38
Critical care technicians: letting nurses be nurses. Interview by Michael Villaire. Crit Care Nurse (1995) 1.38
Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon? Prostaglandins (1981) 1.31
A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. International Society of Radiolabeled Blood Elements (ISORBE) Eur J Nucl Med (1998) 1.25
Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest (2006) 1.23
Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol (2001) 1.22
Labelling of platelets with indium-111 oxine and technetium-99m hexamethylpropylene amine oxime: suggested methods. International Society of Radiolabelled Blood Elements (ISORBE). Eur J Nucl Med (1999) 1.18
A comparative study of root canal preparation using Profile .04 and Lightspeed rotary Ni-Ti instruments. Int Endod J (2002) 1.11
Three-dimensional, non-destructive visualization of vertical root fractures using flat panel volume detector computer tomography: an ex vivo in vitro case report. Int Endod J (2005) 1.11
Diagnosis and root canal treatment of a mandibular second premolar with three root canals. Int Endod J (2003) 1.10
Nonsurgical endodontic management of a double tooth: a case report. Int Endod J (2007) 1.08
Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J Clin Epidemiol (2000) 1.07
Efficacy of different irrigants in the removal of calcium hydroxide from root canals. Int Endod J (2010) 1.07
Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol (1996) 1.07
Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med (1979) 1.06
Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins. N Engl J Med (1984) 1.05
Efficacy of D-RaCe and ProTaper Universal Retreatment NiTi instruments and hand files in removing gutta-percha from curved root canals - a micro-computed tomography study. Int Endod J (2012) 1.04
Prostacyclin generation in atherosclerotic arteries. Lancet (1979) 1.04
Passive smoking and cardiovascular risk. Arch Intern Med (1995) 1.03
Efficacy of reciprocating and rotary NiTi instruments for retreatment of curved root canals assessed by micro-CT. Int Endod J (2014) 1.03
The outcome of retained instrument removal in a specialist practice. Int Endod J (2010) 1.00
Comparison of root canal preparation with two rotary NiTi instruments: ProFile .04 and GT Rotary. Int Endod J (2007) 1.00
A simple and safe technique for sterile autologous platelet labelling using "Monovette" vials. Eur J Nucl Med (1984) 1.00
Effects of fenofibrate on endothelial function and cell adhesion molecules during post-prandial lipemia in hypertriglyceridemia. J Clin Pharm Ther (2003) 1.00
Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women. J Cardiovasc Pharmacol (2000) 0.98
Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest (1986) 0.98
Radiography and bone scintigraphy in multiple myeloma: a comparative analysis. Br J Radiol (1982) 0.98
Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis. Cardiovasc Res (2000) 0.97
Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol (2002) 0.97
Nitric oxide synthesis is increased in periodontal disease. J Periodontal Res (1998) 0.97
Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment. Atherosclerosis (1999) 0.97
Organisation of experimental thrombosis by blood cells. Evidence of the transformation of mononuclear cells into myofibroblasts and endothelial cells. Virchows Arch A Pathol Anat Histopathol (1985) 0.95
Quantitative investigation of sudanophilic lesions around the aortic ostia of human fetuses, newborn and children. Blood Vessels (1980) 0.95
Renin-angiotensin-aldosterone system in cyclosporin A-treated renal allograft recipients. Nephron (1985) 0.95
A comparative study of root canal preparation with NiTi-TEE and K3 rotary Ni-Ti instruments. Int Endod J (2006) 0.93
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers. Thromb Res (2000) 0.93
Reduced umbilical artery prostacyclin formation in complicated pregnancies. Am J Obstet Gynecol (1982) 0.92
Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemia. Wien Klin Wochenschr (1999) 0.92
Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines. J Nucl Med (2000) 0.92
Does vitamin E beneficially affect muscle pains during HMG-Co-enzyme-A-reductase inhibitors without CK-elevation? Atherosclerosis (2000) 0.92
Diminished prostacyclin formation in umbilical arteries of babies born to women who smoke. Lancet (1981) 0.92
Passive smoking severely decreases platelet sensitivity to antiaggregatory prostaglandins. Lancet (1982) 0.91
Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). Thromb Res (2000) 0.90
Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med (1991) 0.90
Efficacy of syringe irrigation, RinsEndo and passive ultrasonic irrigation in removing debris from irregularities in root canals with different apical sizes. Int Endod J (2010) 0.89
Imaging of human atherosclerotic lesions using 123I-low-density lipoprotein. Eur J Nucl Med (1986) 0.89
Influence of radiation synovectomy on articular cartilage, synovial thickness and enhancement as evidenced by MRI in patients with chronic synovitis. J Nucl Med (1999) 0.89
Do human platelets express COX-2? Prostaglandins Leukot Essent Fatty Acids (2001) 0.89
Low cholesterol and cancer. J Clin Oncol (1996) 0.89
Epoprostenol and platelet deposition in atherosclerosis. Lancet (1984) 0.88
Quality of preparation of oval distal root canals in mandibular molars using nickel-titanium instruments. Int Endod J (2002) 0.88
Sensitivity of platelets to prostaglandins in cornary heart disease and angina pectoris. Prostaglandins (1981) 0.88
Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure. J Am Coll Cardiol (1998) 0.88
[Diclofenac and platelet aggregation]. Wien Med Wochenschr (1977) 0.87
The cyclo-oxygenase and lipoxygenase pathways in human oral cancer tissue. J Maxillofac Surg (1984) 0.87
Increase of isoprostane 8-epi-PGF(2alpha)after restarting smoking. Prostaglandins Leukot Essent Fatty Acids (2001) 0.87
Decrease of prostaglandin I2 binding sites in thyroid cancer. Br J Cancer (1988) 0.87
Implanted vascular prostheses generate prostacyclin. Lancet (1978) 0.87
Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus. Diabet Med (2012) 0.87
Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure. Eur Heart J (1996) 0.87
Hyperalphalipoproteinemia and prostaglandin I2 stability. Thromb Res (1997) 0.87
Epoprostenol (prostacyclin) decreases platelet deposition on vascular prosthetic grafts. Lancet (1983) 0.87
[Streptomycin-induced damage of the spiral ganglion]. Acta Otolaryngol (1978) 0.86
Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril. Eur J Heart Fail (2000) 0.86
Platelet function after single [153Sm]EDTMP therapy in prostate cancer. Q J Nucl Med Mol Imaging (2006) 0.86
Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosis. Prostaglandins Leukot Essent Fatty Acids (2002) 0.85
[Apical tooth root resection guideline]. Mund Kiefer Gesichtschir (2007) 0.85
Undergraduate curriculum guidelines for endodontology. Int Endod J (2013) 0.84
[Various forms of the celiac trunk and its anastomoses with the superior mesenteric artery]. Acta Anat (Basel) (1975) 0.84
Local benefit of prostaglandin E2 in radiochemotherapy-induced oral mucositis. Br J Oral Maxillofac Surg (1990) 0.84
Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure. Circulation (2001) 0.84
Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation. Biochem Pharmacol (2001) 0.84
Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand. Br J Cancer (1990) 0.84
Treatment of chronic kidney transplant rejection with prostacyclin - reduction of platelet deposition in the transplant; prolongation of platelet survival and improvement of transplant function. Prostaglandins (1981) 0.84
Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment. Eur J Clin Invest (2009) 0.83
Treatment of hypercholesterolaemia in children. Lancet (1992) 0.83
Regular ingestion of opuntia robusta lowers oxidation injury. Prostaglandins Leukot Essent Fatty Acids (2001) 0.83
Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins Leukot Essent Fatty Acids (2000) 0.83
Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium. Eur J Nucl Med (2000) 0.83
Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor. J Biol Chem (1992) 0.83
Prostacyclin (PGI2)-generation by different types of human atherosclerotic lesions. Exp Pathol (Jena) (1980) 0.83
Daily prickly pear consumption improves platelet function. Prostaglandins Leukot Essent Fatty Acids (2003) 0.83
Maternal cigarette smoking increases F2-isoprostanes and reduces prostacyclin and nitric oxide in umbilical vessels. Prostaglandins Other Lipid Mediat (1999) 0.83
Oral L-arginine administration attenuates postprandial endothelial dysfunction in young healthy males. J Clin Pharm Ther (2001) 0.83
Regulation of human lymph contractility by prostaglandins and thromboxane. Lymphology (1984) 0.82
Comparison of hand and rotary instrumentation for removing gutta-percha from previously treated curved root canals: a microcomputed tomography study. Int Endod J (2013) 0.82
Decreased stability of prostacyclin after acute myocardial infarction. Lancet (1987) 0.82
Recurrence of haemolytic uraemic syndrome triggered by cyclosporin A after renal transplantation. Lancet (1982) 0.82